Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 2/3 1

Status

Unknown 30Completed 19Recruiting 17Terminated 5Not yet recruiting 4Enrolling by invitation 4Active not recruiting 4Withdrawn 1Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 6Gastrointestinal 4Head & Neck 2Tumor-Agnostic 1Genitourinary 1

Conditions

Resectable Esophageal Cancer 1Rectal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer 1

Interventions

Oxaliplatin 87Bevacizumab 68Capecitabine 65Fluorouracil 48tislelizumab 41Gemcitabine 41Drug Therapy 41Leucovorin 38sintilimab 36Irinotecan 35lenvatinib 28Cisplatin 27HMPL-013 24S 1 (combination) 23camrelizumab 22Immune Checkpoint Inhibitors 21irinotecan sucrosofate 20apatinib 20Surgical Procedures, Operative 20Radiotherapy 20Injections 20Paclitaxel 19130-nm albumin-bound paclitaxel 19toripalimab 18Folfox protocol 17pembrolizumab 15Immunotherapy 15Cetuximab 15Specimen Handling 14Radiosurgery 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Chemoradiotherapy × Gastrointestinal × Clear all
NCT07448077 2026-03-04

Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC

Hebei Medical University Fourth Hospital

Phase 2 Not yet recruiting
128 enrolled
Gastrointestinal

Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer

NCT07385664 2026-02-04

FAIR

Zhejiang Cancer Hospital

Phase 2 Not yet recruiting
66 enrolled
Gastrointestinal

Resectable Esophageal Cancer

NCT06861777 2025-03-11

Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2/3 Not yet recruiting
474 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03975049 2019-06-05

Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 3 Not yet recruiting
933 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡